NASDAQ: RNTX
Rein Therapeutics Revenue

Rein Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RNTX annual revenue was $0.0, with N/A growth year-over-year.

RNTX revenue history

Current Revenue
$0.0
Current Earnings
-$62.9M
Current Profit Margin
0%

Be the first to know when RNTX announces revenue.

RNTX Revenue History By Year

RNTX Yearly RevenueRNTX RevenueRNTX ChangeRNTX Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A
2015-12-31$0.00N/AN/A

1 of 1

Rein Therapeutics Revenue FAQ

What was RNTX's revenue last quarter?

On Invalid Date, Rein Therapeutics (NASDAQ: RNTX) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Rein Therapeutics's revenue was $0.00.

What was Rein Therapeutics's revenue in 2024?

Rein Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Rein Therapeutics make in a day?

Based on Rein Therapeutics annual revenue for the past five years, RNTX makes an average of $0.00 per day.

What was Rein Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Rein Therapeutics's revenue has grown null year over year. Rein Therapeutics's revenue in the past year totaled $0.00.

How much does Rein Therapeutics make in a year?

Rein Therapeutics's revenue by year for the past five years is:
  • Rein Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Rein Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Rein Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Rein Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Rein Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.